|
|
| ECZ2043 | Pharmaceutical microbiology | 0+0+3 | ECTS:3 | | Year / Semester | Fall Semester | | Level of Course | Second Cycle | | Status | Compulsory | | Department | DEPARTMENT of PHARMACEUTICS | | Prerequisites and co-requisites | None | | Mode of Delivery | Face to face | | Contact Hours | 14 weeks - 3 hours of laboratory per week | | Lecturer | Prof. Dr. Atila Taner KALAYCIOĞLU | | Co-Lecturer | Doç.Dr. Atila Taner Kalaycıoğlu | | Language of instruction | Turkish | | Professional practise ( internship ) | None | | | | The aim of the course: | | To teach basic and principles of Pharmaceutical microbiology to undergraduate students.
|
| Learning Outcomes | CTPO | TOA | | Upon successful completion of the course, the students will be able to : | | | | LO - 1 : | To be able to list the basic properties of microorganisms such as bacteria, fungi, viruses and parasites and their differences | 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 | 1 | | LO - 2 : | Learns the importance of microbiology in terms of drug industry.
| 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 | 1 | | LO - 3 : | To be able to classify antimicrobials according to their action mechanisms and effect spectra and to explain resistance mechanisms against antimicrobials.
| 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 | 1 | | LO - 4 : | Learns the role of bacteria, fungi, viruses and parasites in disease and important bacterial fungal, viral and parasitic diseases. | 1,2,3,4,5,6,8,9,10,11,12,13,14,15,16,18,19 | 1 | | LO - 5 : | Microbial contamination and preservation of pharmaceutical products, prevention and control of microbial contamination in non-sterile medicines, control of the pharmaceutical factory and good production practices and sterility tests. | 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 | 1 | | LO - 6 : | Has knowledge about hospital infections and zoonotic diseases. | 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 | 1 | | LO - 7 : | knows about the role of Pharmacist in controlling and preventing infectious diseases. | 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 | | | LO - 8 : | Have knowledge about Human microbiome in health and disease | 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19 | | | CTPO : Contribution to programme outcomes, TOA :Type of assessment (1: written exam, 2: Oral exam, 3: Homework assignment, 4: Laboratory exercise/exam, 5: Seminar / presentation, 6: Term paper), LO : Learning Outcome | | |
| The history and working fields of microbiology, Characteristics and classification of bacteria, chlamydia, rickettsia, fungi, parasites and viruses, Pharmaceutical industry and microbiology, Bacterial metabolism and genetic, Antibiotics and antibiotic resistance development mechanisms, Host parasite associations, Infection diseases and the role of pharmacist, Role of bacteria, fungi, viruses, prions and parasites in disease and important diseases which they cause, Hospital infections and emerging diseases and human microbiome in health and disease. |
| |
| Course Syllabus | | Week | Subject | Related Notes / Files | | Week 1 | History of Microbiology and General Properties of Microorganisms
Practical 1: Microbiology Laboratory Rules and Biosafety | | | Week 2 | Pharmaceutical Industry and Microbiology
Practical 2. The introduction of tools and equipments used in microbiology laboratory
| | | Week 3 | Bacterial classification and structure
Practical 3. Use of microscopes | | | Week 4 | Reproduction of Bacteria and Factors Affecting Reproduction
Practical 4: Types of Culture Media, Cultivation methods and Specimen Collection | | | Week 5 | Bacterial Metabolism and Genetic
Practical 5: Bacterial Morphology and Bacteria Staining (Simple Staining, Compound-Gram Staining)
| | | Week 6 | Antibiotics and Resistance Development Mechanisms
Practical 6: Antibiotic Sensitivitiy Tests | | | Week 7 | Human Microbiome Health and Disease
Practical 7: Molecular Microbiological Methods and Microbiome Studies | | | Week 8 | Infectious Diseases and Pathogenesis-Host Parasite Relationships | | | Week 9 | Midterm | | | Week 10 | Infectious Diseases and Clinical Pharmacy | | | Week 11 | Emerging Infectious Diseases
Practical 8: Diagnosis of Emerging Infectious Agents | | | Week 12 | Hospital Acquired Infections
Practical 9: Serologic Diagnostic Methods | | | Week 13 | Bacterial and Fungal Infections
Practical 10: Laboratory Diagnosis of Bacteria and Fungal Infections | | | Week 14 | Viral and Prion Diseases
Uygulama 11. Diagnosis of Viral Diseases and Bioinformatic | | | Week 15 | Parasitic Infections
Practical 12: Diagnosis of Parasitic Infections | | | Week 16 | Final exam | | | |
| 1 | Farmasötik Mikrobiyoloji, Abbasoğlu U, Çevikbaş A, 2015. Elif Yayınevi, ISBN 978-605-4334-79-7 | | | 2 | Medical Microbiology,. Murray P.R, Rosenthal K.S, Pfaller M.A.(Eds) Elsevier, 2013 Seventh Edition, ISBN 978-032308692-9 | | | 3 | Fenner and White's Medical Virology 5th Edition, Burrell C, Howard C, Murphy F, 2016, Academic Press, ISBN: 9780123751560 | | | |
| Method of Assessment | | Type of assessment | Week No | Date | Duration (hours) | Weight (%) | | Mid-term exam | 8 | 11.11.2019 | 1 | 50 | | End-of-term exam | 16 | 03.01.2020 | 1 | 50 | | |
| Student Work Load and its Distribution | | Type of work | Duration (hours pw) | No of weeks / Number of activity | Hours in total per term | | Yüz yüze eğitim | 3 | 14 | 42 | | Sınıf dışı çalışma | 3 | 14 | 42 | | Laboratuar çalışması | 3 | 14 | 42 | | Arasınav için hazırlık | 3 | 2 | 6 | | Arasınav | 2 | 1 | 2 | | Ödev | 2 | 2 | 4 | | Kısa sınav | 2 | 1 | 2 | | Dönem sonu sınavı için hazırlık | 3 | 2 | 6 | | Dönem sonu sınavı | 2 | 1 | 2 | | Diğer 1 | 2 | 1 | 2 | | Total work load | | | 150 |
|